MAPT and Alzheimer disease: A definitive diagnosis of AD remains to be only possible via neuropathological examination that demonstrates the presence of the classical disease hallmarks, namely amyloid-β (Aβ) plaques together with tau neurofibrillary tangles (NFT) [6, 14].